Fig. 2From: Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancerKaplan–Meier PFS and OS for all patients. TRT, thoracic radiotherapy; PFS, progression-free survival; OS, overall survival; mo: months; CI, confidence intervalBack to article page